Karan Nagarakere Ramakrishna, MBBS

Karan Ramakrishna practices at URochester Jones Memorial Hospital in Wellsville, New York, part of University of Rochester Medical Center.

Karan Ramakrishna's NPI, 1427578053, was assigned on June 24, 2017. Karan Ramakrishna holds New York license 329079.

Karan Ramakrishna's primary practice is URochester Jones Memorial Hospital, at 191 North Main Street, Wellsville, NY 14895 in Allegany County. The practice phone is (585) 593-1100.

Karan Ramakrishna's primary practice is URochester Jones Memorial Hospital in Wellsville, New York, part of University of Rochester Medical Center. Karan Ramakrishna is also affiliated with WVU Medicine Princeton Community Hospital. The medical group on file is Jones Memorial Hospital. Dmand AI also links Karan Ramakrishna to 2 more hospitals and 1 medical group, each named with a free account.

Dmand AI tracks the electronic health record (EHR) system at each site where Karan Ramakrishna practices, 4 sites in all. Vendor and product names are available with a free account.

Hematology and oncology is Karan Ramakrishna's primary specialty in the NPI Registry, under taxonomy code 207RH0003X. Karan Ramakrishna is licensed in New York.

CMS data shows 82 Medicare services from Karan Ramakrishna across 2 procedure codes in 2024, all of them office visits, for 62 Medicare patients. Medicare paid $7,913 for them.

CMS counts 62 Medicare patients who saw Karan Ramakrishna in 2024. The largest group is 65 to 74, with 28 patients. 75% of them have high blood pressure, and 75% have high cholesterol. 26% are also on Medicaid. Their average risk score is 1.64, where 1.00 is the Medicare average, so they are sicker than most Medicare patients.

Across all payers, Dmand AI patient panel data puts Karan Ramakrishna's median patient age at 69, with 59% women.

In 2024, Karan Ramakrishna wrote 82 Medicare Part D claims for 37 patients. 84% of them were for generic drugs. CMS names the drug for 11 of them, across 1 drug with 11 or more claims each, at $383 in total drug cost. In 2020, CMS named 13 claims across 1 drug.

CMS publishes a Merit-based Incentive Payment System (MIPS) score of 88 out of 100 for Karan Ramakrishna for performance year 2024, reported as part of a group. Karan Ramakrishna accepts Medicare assignment, so Medicare's approved amount is taken as full payment.

Dmand AI links 7 papers to Karan Ramakrishna, published from 2019 to 2023. 2019 was the busiest year, with 4. Karan Ramakrishna's most frequent co-authors are Harvir Singh Gambhir, MD, Gautam Gopalji Jha, MD and Uma K. Murthy, MD.

CMS Open Payments shows 1 general payment to Karan Ramakrishna from 1 drug or device company in 2025. Education make up the largest share, 100% of the total. Pfizer Inc. paid the most, $31.